MedTrace Logo

Balance Dimensions-Based Rehabilitation Program in People With Acquired Brain Injury

NCT07696663 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2026-07-10

No results posted yet for this study

Summary

The purpose of this clinical trial is to find out whether a rehabilitation program based on different dimensions of balance can improve balance, mobility, walking ability, and quality of life in people with acquired brain injury.

The main questions this study aims to answer are:

* Does this rehabilitation program improve balance?
* Does it improve mobility and walking ability?
* Does it reduce the risk of falls?
* Does it improve quality of life?

Researchers will compare a specific balance rehabilitation program with conventional physiotherapy to determine whether the balance program provides additional benefits.

Participants with acquired brain injury who meet the eligibility criteria will be randomly assigned to one of two groups. Both groups will receive treatment for 12 weeks.

Participants will:

* Complete balance and mobility assessments before starting treatment.
* Receive either the balance rehabilitation program or conventional physiotherapy five times per week.
* Complete assessments immediately after treatment and again 6 and 12 weeks later.

The information obtained from this study may help improve rehabilitation programs and daily functioning for people with acquired brain injury.

Conditions

  • Acquired Brain Injury
  • Balance Disorders

Interventions

BEHAVIORAL

Multimodal Balance Rehabilitation Program

A multimodal rehabilitation program based on balance dimensions designed to improve balance performance in people with acquired brain injury.

OTHER

Conventional Physiotherapy

Conventional physiotherapy routinely provided at CEADAC according to standard clinical practice.

Sponsors & Collaborators

  • Centro de Referencia Estatal de Atención Al Daño Cerebral

    collaborator OTHER

  • University of Castilla-La Mancha

    lead OTHER

Principal Investigators

  • Marta Fernández Hontoria, MSc · Centro de Referencia Estatal de Atención al Daño Cerebral (CEADAC), IMSERSO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07696663 on ClinicalTrials.gov